The Defeat Parkinson’s Platform is supported by institutional funds from the Charitable Hertie Foundation, the University of Tübingen, the German Center for Neurodegenerative Diseases (DZNE) and by…
Researchers and physicians of the Defeat Parkinson's Platform are active and often leading members of many international research networks:
the International Parkinson's Disease Genomics…
The DZNE Tübingen, the HIH and the clinical neurology department have created a state of the art platform for genomic research, using transcriptomics, epigenetics, proteomics and high-throughput…
The nobelprize-winning discovery that differentiated cells can be turned into induced pluripotent stemc cells (IPSCs) and then made to differentiate into almost any cell type has revolutionized…
Many of our patients have consented to be screened for genetic variants that may cause or influence the course of the disease. Together with many collaborators world-wide, we are therefore able to…
Together with the DZNE, the Center of Neurology in Tübingen jointly runs one of the largest BioBanks for Parkinson's disease worldwide. For example, more than 4000 DNA samples, 2000 CSF and blood…
Since more than 10 years, physicians at the clinical Department of Neurodegenerative diseases have systematically followed patients with Parkinson's disease and persons at risk for PD and other…
The clinical Department of Neurodegenerative Diseases runs the largest Parkinson's outpatient clinic in southern Germany, specialized in early and differential diagnosis of the disorder. Patients…
